Citizens Maintains Market Outperform on LeonaBio, Lowers Price Target to $17
LeonaBio, Inc.
LeonaBio, Inc. LONA | 0.00 |
Citizens analyst Jason N. Butler maintains LeonaBio (NASDAQ:
LONA) with a Market Outperform and lowers the price target from $18 to $17.
